search
Back to results

Prehabilitation and Posttransplant Training Program in Liver Transplantation (PreLiveR-T)

Primary Purpose

Liver Transplant; Complications, Cirrhosis, Liver, Hepatic Carcinoma

Status
Enrolling by invitation
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Prehabilitation
Prehabilitation and posttransplant training program
Sponsored by
Maria dels Angels Cebria i Iranzo, PT, PhD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Liver Transplant; Complications focused on measuring Prehabilitation, Therapeutic Exercise, Functional capacity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Indication of elective liver transplant with favorable cardiorespiratory evaluation that does not contraindicate the transplant.

Exclusion Criteria:

  • Any orthopedic, motor, functional, neurological, cognitive or linguistic limitation that prevents the realization of the Prehabilitation program
  • Inability to perform psychometric tests
  • Esophageal varices not treated with ligature or beta-blockers
  • Varicose veins with a high risk of digestive hemorrhage
  • Hemoglobin <80 g/l
  • Contraindication to weight loading
  • Impossibility to comply with the Prehabilitation program (hospital admission, work, geographical location)
  • Multi-organ transplantation and liver retransplantation
  • Refusal or lacks capacity to give informed consent

Sites / Locations

  • Hospital Universitari i Politècnic La Fe

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Experimental

Arm Label

Control group

Prehabilitation group

Prehabilitation and posttransplant training group

Arm Description

Conventional medical care

Conventional medical care and 8 weeks of a Prehabilitation supervised program

Conventional medical care, 8 weeks of a Prehabilitation supervised program and a posttransplant training program.

Outcomes

Primary Outcome Measures

Morbidity
Registry of post-surgical complications according to the Clavien-Dindo classification. Reference: Ann Surg 2004; 240(2):205-13.
Mortality
Registry of mortality
Number of hospitalization days
Registry of number of days of hospitalization in intensive care unit and ward.
Number of days with supplementary oxygen therapy and/or mechanical ventilation
Registry of number of days
Progression in the activities of daily life (ADL)
Days of acquisition, sitting, walking and stairs

Secondary Outcome Measures

Change in functional capacity: measurement of oxygen uptake
Cardiopulmonary exercise test following an incremental protocol on ramp with a bicycle ergometer.
Change in functional capacity: 6-minutes walking test (6MWT)
6MWT is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6 MWT provides information regarding functional capacity, response to therapy and prognosis. American Thoracic Society (ATS) Statement Guidelines for the Six-Minute Walk Test. Am J Resp Crit Care Med 2002;166(1):111-117
Change in peripheral muscle strength: handgrip strength, quadriceps femoris strength and biceps brachii strength
Isometric peripheral muscle strength will be measured using a digital hand dynamometer and the unit of measure is kilograms. References: Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall CC, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age and Ageing 2011;40(4):423-9. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996; 76(3):248-59
Change in respiratory strength: maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)
Maximum respiratory pressures will be measured using a Respiratory Pressure Meter MicroRPM® and the unit of measure is cmH2O. MIP and MEP are probably the most frequently reported non-invasive estimates of respiratory muscle strength. Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes. Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal breathing. Reference: Am J Respir Crit Care Med. 2002;166:531-535
Change in performance on the Short Physical Performance Battery (SPPB)
The SPPB is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines three areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. Static balance is measured in units of time (seconds) and patients are timed holding 3 different stances. Gait speed is measured in time (seconds) to walk 4 meters. Chair sits are measured as the time (seconds) it takes to get up and out of a chair 5 times without using one's arms to assist the exercise. Collectively, the three tests are used to generate a total score (0-12) that reflects a patient's frailty (score of 0) or lack of frailty (score of 12). Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.
Change in muscle mass
Bioelectrical impedance analysis will be completed using the Bodystat 1500 MDD, which is a multi-frequency body composition analyzer. Body fat percentage (%) will be compared to lean body mass percentage and total body water percentage to assess sarcopenia and nutritional status.
Change in Quality of life
Short-Form Liver Disease Quality of Life (SF-LDQOL) is formed by 9 dimensions: symptoms of the disease, effects of the disease on the activities of daily life, memory/concentration, anxiety, sleep, loneliness, hopelessness, stigma for the disease and sexual functioning. The minimum and maximum values of the scale are 0-100, so that the higher the score, the better health related quality of life (HRQL).

Full Information

First Posted
January 20, 2020
Last Updated
February 28, 2023
Sponsor
Maria dels Angels Cebria i Iranzo, PT, PhD
Collaborators
University of Valencia
search

1. Study Identification

Unique Protocol Identification Number
NCT04246970
Brief Title
Prehabilitation and Posttransplant Training Program in Liver Transplantation
Acronym
PreLiveR-T
Official Title
Effects of a Prehabilitation Program in Liver Transplant Candidates Followed by a Posttransplant Training Program
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
April 1, 2021 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
January 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Maria dels Angels Cebria i Iranzo, PT, PhD
Collaborators
University of Valencia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
PreLiveR-T consists of a prospective randomized clinical trial conducted in an adult population that is a candidate for liver transplantation (LT) at the Hospital La Fe Valencia (Spain). The study is structured in three phases: I) Prehabilitation (2 months before LT); II) Training, divided in two successive periods: Supervised training (months 3-6 after LT) and Unsupervised training (6-12 months after LT); III) Long-term follow-up (2 years after LT). Primary outcomes are related to post-surgery evolution (morbidity and mortality, hospitalization length, etc.). As a secondary outcomes are collected those related to: functional capacity, muscle strength and quality of life.
Detailed Description
The main objective is to study the post-surgical impact (post-S) of a Prehabilitation program on candidates for liver transplantation (LT), as well as to study the effects of posttransplant training on the clinical and functional evolution of the recipients. Also this project pretends to assess the influence of functional capacity (FC) improvement on the short and long term post-S evolution of the LT candidates. This is a prospective randomized clinical trial in which three phases follow: Prehabilitation, training and follow-up. The sample will be constituted by 60 candidates for LT, randomized in a control group (CG, n=20), a Prehabilitation group (PG, n=20) and a Prehabilitation-posttransplant training group (PTG, n=20). To conventional care, a Prehabilitation program will be added to the PG and PTG. After the LT, just PTG will follow a posttransplant training program. The long-term follow-up will be extended to 2 years post-LT. The variables under study will be: complications and post-S evolution; FC; quality of life; etc. The individualization of Prehabilitation and posttransplant training program, and also medical control, will ensure safety and offer the potential benefits that these types of programs can provide.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Transplant; Complications, Cirrhosis, Liver, Hepatic Carcinoma
Keywords
Prehabilitation, Therapeutic Exercise, Functional capacity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
Conventional medical care
Arm Title
Prehabilitation group
Arm Type
Experimental
Arm Description
Conventional medical care and 8 weeks of a Prehabilitation supervised program
Arm Title
Prehabilitation and posttransplant training group
Arm Type
Experimental
Arm Description
Conventional medical care, 8 weeks of a Prehabilitation supervised program and a posttransplant training program.
Intervention Type
Other
Intervention Name(s)
Prehabilitation
Other Intervention Name(s)
Interval aerobic exercise, peripheral and respiratory muscle training, balance exercise
Intervention Description
Supervised training program of 8-weeks and a frequency of 2 days/week. It includes interval aerobic exercise (5 cycles of 2 minutes at 70 percentage of Watts or heart rate of cardiopulmonary exercise testing (CEPT) and 3 minutes of active rest at 40 percentage; peripheral muscle training and balance exercises in a circuit of 10 phases, 10 to 15 repetitions, from 1 to 3 sets (the participants will work at moderate intensity, no more than 5-6/10 on the modified Borg scale); Inspiratory Muscle Training (IMT) through a threshold loading device [2 sessions / day, 3 sets of 15 repetitions, at 60-70 percentage of the maximum inspiratory pressure (cmH2O)]; ventilatory reeducation by an incentive inspirator based on the vital capacity evaluated in the initial spirometry. Both the aerobic modality and the resistance training, will increase the intensity of work (HR, Watts, Kg or cmH2O) between 2-5 percentage every 2 weeks complying with the principle of training overload.
Intervention Type
Other
Intervention Name(s)
Prehabilitation and posttransplant training program
Other Intervention Name(s)
Interval aerobic exercise, peripheral muscle training and balance exercise
Intervention Description
Prehabilitation will be followed by a posttransplant training program. In this, the patient will perform supervised exercise (IIa interval aerobic exercise and resistance training) 2 days / week, and a physical exercise program at home until completing a total of 5 sessions / week in the aerobic modality. In the unsupervised phase (IIb), the patient will continue with the learned physical exercise program, but without supervision, 5 sessions / week (including a minimum of 2 non-consecutive sessions to perform resistance training).
Primary Outcome Measure Information:
Title
Morbidity
Description
Registry of post-surgical complications according to the Clavien-Dindo classification. Reference: Ann Surg 2004; 240(2):205-13.
Time Frame
The groups will be assessed from the hospitalization up to 24-months.
Title
Mortality
Description
Registry of mortality
Time Frame
The groups will be assessed from the hospitalization until the date of death, assessed up to 24-months.
Title
Number of hospitalization days
Description
Registry of number of days of hospitalization in intensive care unit and ward.
Time Frame
The groups will be assessed during hospitalization, approximately 7 days.
Title
Number of days with supplementary oxygen therapy and/or mechanical ventilation
Description
Registry of number of days
Time Frame
The groups will be assessed during hospitalization, approximately 7 days.
Title
Progression in the activities of daily life (ADL)
Description
Days of acquisition, sitting, walking and stairs
Time Frame
The groups will be assessed during hospitalization, approximately 7 days.
Secondary Outcome Measure Information:
Title
Change in functional capacity: measurement of oxygen uptake
Description
Cardiopulmonary exercise test following an incremental protocol on ramp with a bicycle ergometer.
Time Frame
The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.
Title
Change in functional capacity: 6-minutes walking test (6MWT)
Description
6MWT is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6 MWT provides information regarding functional capacity, response to therapy and prognosis. American Thoracic Society (ATS) Statement Guidelines for the Six-Minute Walk Test. Am J Resp Crit Care Med 2002;166(1):111-117
Time Frame
The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.
Title
Change in peripheral muscle strength: handgrip strength, quadriceps femoris strength and biceps brachii strength
Description
Isometric peripheral muscle strength will be measured using a digital hand dynamometer and the unit of measure is kilograms. References: Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall CC, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age and Ageing 2011;40(4):423-9. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996; 76(3):248-59
Time Frame
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
Title
Change in respiratory strength: maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)
Description
Maximum respiratory pressures will be measured using a Respiratory Pressure Meter MicroRPM® and the unit of measure is cmH2O. MIP and MEP are probably the most frequently reported non-invasive estimates of respiratory muscle strength. Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes. Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal breathing. Reference: Am J Respir Crit Care Med. 2002;166:531-535
Time Frame
The groups will be assessed at baseline and at week 8.
Title
Change in performance on the Short Physical Performance Battery (SPPB)
Description
The SPPB is a simple test to measure lower extremity function using tasks that mimic daily activities. The SPPB examines three areas of lower extremity function; static balance, gait speed, and getting in and out of a chair. Static balance is measured in units of time (seconds) and patients are timed holding 3 different stances. Gait speed is measured in time (seconds) to walk 4 meters. Chair sits are measured as the time (seconds) it takes to get up and out of a chair 5 times without using one's arms to assist the exercise. Collectively, the three tests are used to generate a total score (0-12) that reflects a patient's frailty (score of 0) or lack of frailty (score of 12). Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.
Time Frame
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
Title
Change in muscle mass
Description
Bioelectrical impedance analysis will be completed using the Bodystat 1500 MDD, which is a multi-frequency body composition analyzer. Body fat percentage (%) will be compared to lean body mass percentage and total body water percentage to assess sarcopenia and nutritional status.
Time Frame
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
Title
Change in Quality of life
Description
Short-Form Liver Disease Quality of Life (SF-LDQOL) is formed by 9 dimensions: symptoms of the disease, effects of the disease on the activities of daily life, memory/concentration, anxiety, sleep, loneliness, hopelessness, stigma for the disease and sexual functioning. The minimum and maximum values of the scale are 0-100, so that the higher the score, the better health related quality of life (HRQL).
Time Frame
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Indication of elective liver transplant with favorable cardiorespiratory evaluation that does not contraindicate the transplant. Exclusion Criteria: Any orthopedic, motor, functional, neurological, cognitive or linguistic limitation that prevents the realization of the Prehabilitation program Inability to perform psychometric tests Esophageal varices not treated with ligature or beta-blockers Varicose veins with a high risk of digestive hemorrhage Hemoglobin <80 g/l Contraindication to weight loading Impossibility to comply with the Prehabilitation program (hospital admission, work, geographical location) Multi-organ transplantation and liver retransplantation Refusal or lacks capacity to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maria A Cebrià i Iranzo, PT, PhD
Organizational Affiliation
Hospital Universitari i Politècnic La Fe, Valencia
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
David Calatayud Mizrahi, MD, PhD
Organizational Affiliation
Hospital Universitari i Politècnic La Fe, Valencia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Natalia Cezón Serrano, PT
Organizational Affiliation
University of Valencia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Luis Compte Torrero, MD, PhD
Organizational Affiliation
Hospital Universitari i Politècnic La Fe, Valencia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Laura Arjona Tinaut, PT
Organizational Affiliation
University of Valencia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Rafael López Andújar, MD, PhD
Organizational Affiliation
Hospital Universitari i Politècnic La Fe, Valencia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Martín Prieto Castillo, MD, PhD
Organizational Affiliation
Hospital Universitari i Politècnic La Fe, Valencia
Official's Role
Study Chair
Facility Information:
Facility Name
Hospital Universitari i Politècnic La Fe
City
Valencia
ZIP/Postal Code
46026
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28489682
Citation
Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293.
Results Reference
background
PubMed Identifier
29162460
Citation
Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):205-215. doi: 10.1016/j.clinre.2017.09.005. Epub 2017 Nov 20.
Results Reference
background
PubMed Identifier
25531893
Citation
Debette-Gratien M, Tabouret T, Antonini MT, Dalmay F, Carrier P, Legros R, Jacques J, Vincent F, Sautereau D, Samuel D, Loustaud-Ratti V. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015 Jan;99(1):145-50. doi: 10.1097/TP.0000000000000245.
Results Reference
background
PubMed Identifier
30859755
Citation
Williams FR, Vallance A, Faulkner T, Towey J, Durman S, Kyte D, Elsharkawy AM, Perera T, Holt A, Ferguson J, Lord JM, Armstrong MJ. Home-Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study. Liver Transpl. 2019 Jul;25(7):995-1006. doi: 10.1002/lt.25442. Epub 2019 Jun 6.
Results Reference
background

Learn more about this trial

Prehabilitation and Posttransplant Training Program in Liver Transplantation

We'll reach out to this number within 24 hrs